(Q52228737)

27 April 2018

title

Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. (English)

1 reference

27 April 2018

1 reference

1

M Papp

1 reference

27 April 2018

P Willner

2

1 reference

27 April 2018

R Muscat

series ordinal

3

1 reference

27 April 2018

publication date

1 January 1993

1 reference

27 April 2018

published in

Psychopharmacology

1 reference

27 April 2018

volume

110

1 reference

27 April 2018

page(s)

159-164

1 reference

27 April 2018

issue

1-2

1 reference

27 April 2018

https://scigraph.springernature.com/pub.10.1007/bf02246966

exact match

0 references

cites work

Assessing anhedonia in psychiatric patients.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246966

Environmental influences on behavioural sensitization to the dopamine agonist quinpirole.

21 January 2018

1 reference

12 December 2020

Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine.

1 reference

12 December 2020

Antidepressant-like effects of dopamine agonists in an animal model of depression.

1 reference

12 December 2020

Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.

1 reference

12 December 2020

An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

1 reference

12 December 2020

Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat.

1 reference

12 December 2020

Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress.

1 reference

12 December 2020

Dopaminergic mechanism of imipramine action in an animal model of depression

1 reference

12 December 2020

Context-dependent cocaine sensitization: differential effect of haloperidol on development versus expression

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

Reversal of antidepressant action by dopamine antagonists in an animal model of depression

1 reference

12 December 2020

Changes in dopamine autoreceptor sensitivity in an animal model of depression

1 reference

12 December 2020

Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant

1 reference

12 December 2020

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

1 reference

12 December 2020

Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

1 reference

12 December 2020

Chronic administration of a selective dopamine D-2 agonist: factors determining behavioral tolerance and sensitization

1 reference

12 December 2020

Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.

1 reference

12 December 2020

Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats

1 reference

12 December 2020

Decrease in hypothalamic epinephrine concentration and other neurochemical changes produced by quinpirole, a dopamine agonist, in rats

1 reference

12 December 2020

Conditioning and experiential factors affecting the development of sensitization to apomorphine.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02246966

1 reference

27 April 2018

PubMed ID

7870877

1 reference

27 April 2018